Surgery Partners is trading 5.12% down at $13.16, amid broader healthcare-sector pressure; available coverage has not identified a company-specific catalyst for the October 1, 2026 decline.
- The decline follows several weaker sessions.
- Rising Treasury yields and lingering concerns about healthcare pricing policy are weighing on the sector.
- The latest company news was its September Idaho Falls facilities sale and updated guidance.